StockCIK 907654

Oruka Therapeutics, Inc. (ORKA): Insider Trades and Fund Holdings

In the past 12 months, Oruka Therapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 17 sales worth $22.0M; 14 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$22.0MSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 20, 2026.

Recent ORKA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 20	Oct 20	Paul T. QuinlanGeneral Counsel	General Counsel	▼ SELL10b5-1	9,000	78.53	$707K	−23%	Form 4 ↗
Oct 15	Oct 15	Joana GoncalvesChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	7,000	74.81	$524K	−18%	Form 4 ↗
Oct 13	Oct 12	Arjun AgarwalPresident	President	▼ SELL10b5-1	9,999	80.60	$806K	−41%	Form 4 ↗
Oct 2	Oct 1	Lawrence Otto KleinCEO	CEO	▼ SELL10b5-1	25,000	83.62	$2.09M	−2.6%	Form 4 ↗
Sep 21	Sep 21	Paul T. QuinlanGeneral Counsel	General Counsel	▼ SELL10b5-1	10,000	93.64	$936K	−25%	Form 4 ↗
Sep 21	Sep 21	Arjun AgarwalPresident	President	▼ SELL10b5-1	533	95.75	$51K	−3.6%	Form 4 ↗
Sep 15	Sep 11	Arjun AgarwalPresident	President	▼ SELL10b5-1	9,459	92.23	$872K	−38%	Form 4 ↗
Sep 15	Sep 15	Joana GoncalvesChief Medical Officer	Chief Medical Officer	▼ SELL10b5-1	7,947	92.38	$734K	−20%	Form 4 ↗
Sep 15	Sep 15	Lawrence Otto KleinCEO	CEO	▼ SELL	2,452	95.71	$235K	−0.3%	Form 4 ↗
Sep 15	Sep 15	Paul T. QuinlanGeneral Counsel	General Counsel	▼ SELL	1,039	95.71	$99K	−3.3%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

All 17 ORKA insider trades →

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Paul T. Quinlan	General Counsel	$0	4	$7.38M	Oct 20, 2026
Joana Goncalves	Chief Medical Officer	$0	3	$2.04M	Oct 15, 2026
Arjun Agarwal	President	$0	5	$2.85M	Oct 13, 2026
Lawrence Otto Klein	CEO	$0	3	$9.21M	Oct 2, 2026
Laura Lee Sandler	COO	$0	2	$546K	Sep 15, 2026

Tracked funds that report ORKA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Viking Global Investors	Q2 2026	1,503,478	$143.1M	0.41%	▼ −43.6%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →